Peak6 Investments LLC Royalty Pharma PLC Call Options Transaction History

Peak6 Investments LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 13, 2023	SELL	$26.26 - $31.38 $39,390 - $47,070	-1,500 Reduced 16.48%	7,600 $206,000
Q2 2023 Aug 11, 2023	SELL	$29.6 - $36.56 $473,600 - $584,960	-16,000 Reduced 63.75%	9,100 $279,000
Q1 2023 May 12, 2023	SELL	$32.77 - $39.4 $160,573 - $193,060	-4,900 Reduced 16.33%	25,100 $904,000
Q4 2022 Feb 10, 2023	SELL	$39.17 - $44.04 $1.21 Million - $1.36 Million	-30,900 Reduced 50.74%	30,000 $1.19 Million
Q2 2022 Aug 12, 2022	BUY	$37.53 - $44.22 $2.29 Million - $2.69 Million	60,900 New	60,900 $2.56 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.